Warning! As of 20 September 2021, the EU lobby register has changed format. Temporarily, the register is no longer providing daily data updates of all lobby data which means that the figures on LobbyFacts cannot currently be kept up-to-date. If, for example, you see a company, trade association, or lobby consultancy with "no figure available" for EU lobby costs, open the data card, and click the link to the EU lobby register where you will find the updated registration including EU lobby costs declaration. Regretably, under the lobby register format, NGOs and think tanks are no longer required to provide a figure for EU lobby costs. We will update LobbyFacts with the new data as soon as possible.

Tweet this page
How to read and use this data card.

Lobbying costs:

WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.

WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.

No figure available

Financial year: -

Lobbyists declared: 2.25 FTE (6)

WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.


Lobbyists with EP accreditation: 0

Meetings with European Commission: 20

Lobbying costs over the years:



Registration on EU Transparency Register

61291462764-77 (First registered: 11 Dec 2009)

Goals / Remit

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

Sanofi, Empowering Life.


- Digital in Healthcare - European Health Data Space - future Health Emergency Response Authority - pandemic preparedness - cross-border health threats - shortages of medicines/EU Structured Dialogue - manufacturing/value-chain of pharmaceuticals - EU Vaccines policies and vaccine-related activities - European green deal agenda - EU pharmaceutical strategy - EU Competitiveness and Industrial policy - EU Research policy / framework program - EU options for improving access to medicines - Health Technology Assessment Regulation proposal - Innovative Medicines Initiative (IMI) - Medical Devices Regulation - Paediatric Regulation - Pharmaceuticals in the environment - Protection of animals used for scientific purposes Directive - Regulation on Orphan Medicinal Products - Reach - Trade Agreements


Head office:
SANOFI GROUPE 54, rue la Boétie 54, rue la Boétie
Paris 75008

Tel: 33 1 53 77 40 00